Apotheek Suys
ActiveApotheek Suys has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €185k and a net result of €-3k. Equity is growing by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 42% of 9625 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2024
62
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability35▼-1
Solvency57▼-2
Growth52=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity ample (current ratio 1.69 against 1.83 in 2023; short-term debt: 50.5% and cash: 43.1% of total assets), but 68.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
31.9%
Return on assets
-0.6%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-04-2025, 98 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
98 d early
2023
16 d early
2022
11 d early
2021
22 d late
2020
61 d late
2019
52 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€185k▼ 1.7%
2023 · €189k
2018: €151k
2019: €151k
2020: €146k
2021: €194k
2022: €192k
2023: €189k
2018 → 2024
Total assets
€581k▲ 4.9%
2023 · €553k
2018: €303k
2019: €319k
2020: €540k
2021: €503k
2022: €512k
2023: €553k
2018 → 2024
Net result
€-3k▲ 7.2%
2023 · €-4k
2018: €-741
2019: €-4k
2020: €-4k
2021: €51k
2022: €-2k
2023: €-4k
2018 → 2024
Working capital
€203k▲ 1.0%
2023 · €201k
2018: €149k
2019: €142k
2020: €138k
2021: €189k
2022: €193k
2023: €201k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€146k-€194k▲ 32.8%€192k▼ 1.2%€189k▼ 1.8%€185k▼ 1.7%
Operating result€16k-€71k▲ 352%€21k▼ 70.0%€20k▼ 4.1%€22k▲ 6.4%
Net result€-4k-€51k€-2k€-4k▼ 58.5%€-3k▲ 7.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 6% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €581k
Fixed assets
€85k▼ 23.0%
Current assets
€496k▲ 11.8%
Equity and liabilities €581k
Equity
€185k▼ 1.7%
Debt
€395k▲ 8.4%
The debt ratio rises from 65.9% to 68.1%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€52k▼
2023 · €52k
Cash flow
€27k▼
2023 · €28k
Solvency
31.9%▼
2023 · 34.1%
Current ratio
1.69▼
2023 · 1.83
Quick ratio
0.89▼
2023 · 1.00
Debt / equity
2.13▲
2023 · 1.93
ROE
-1.8%▲
2023 · -1.9%
ROA
-0.6%▲
2023 · -0.6%
Interest coverage
2.07▼
2023 · 2.17
Debt
€395k▲
2023 · €365k
Debt ≤ 1 year
€293k▲
2023 · €243k
Debt > 1 year
€102k▼
2023 · €122k
Income taxes
€425
Staff costs
€171k▲
2023 · €141k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€553k€581k▲
Fixed assets21/28€110k€85k▼
Tangible fixed assets22/27€110k€85k▼
Plant, machinery and equipment23€17k€4k▼
Furniture and vehicles24€5k€4k▼
Other tangible fixed assets26€88k€77k▼
Current assets29/58€444k€496k▲
Stocks and contracts in progress3€201k€235k▲
Stocks30/36€201k€235k▲
Amounts receivable within one year40/41€105k€2k▼
Trade receivables40€105k€2k▼
Other amounts receivable41€0-
Current investments50/53€951€951=
Cash at bank and in hand54/58€130k€250k▲
Deferred charges and accrued income490/1€7k€7k▲
Equity and liabilities
Total equity and liabilities10/49€553k€581k▲
Equity10/15€189k€185k▼
Contributions10/11€20k€20k=
Reserves13€110k€110k=
Distributable reserves133€110k€110k=
Profit (loss) carried forward14€59k€56k▼
Amounts payable17/49€365k€395k▲
Amounts payable after more than one year17€122k€102k▼
Financial debts170/4€122k€102k▼
Amounts payable within one year42/48€243k€293k▲
Current portion of amounts payable after more than one year42€20k€20k▲
Trade debts44€193k€226k▲
Suppliers440/4€193k€226k▲
Taxes, remuneration and social security45€20k€31k▲
Taxes450/3€1k€3k▲
Remuneration and social security454/9€19k€28k▲
Other amounts payable47/48€9k€16k▲
Income statement
Code20232024
Remuneration, social security and pensions62€141k€171k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€32k€30k▼
Other operating charges640/8€969€988▲
Non-recurring operating charges66A€0-
Gross operating margin9900€194k€224k▲
Operating profit (loss)9901€20k€22k▲
Financial income75/76B€210€543▲
Recurring financial income75€210€543▲
Financial charges65/66B€24k€25k▲
Recurring financial charges65€24k€25k▲
Profit (loss) for the period before taxes9903€-4k€-3k▲
Income taxes67/77-€425
Profit (loss) for the period9904€-4k€-3k▲
Profit (loss) for the period to be appropriated9905€-4k€-3k▲
Appropriation of the result
Profit (loss) to be appropriated9906€59k€56k▼
Profit (loss) brought forward from the previous period14P€62k€59k▼
Social balance
Average headcount (FTE)90872.12.8▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
14-08
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment5 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment5 facts ▸
- General meeting, 05/08/2026
- Director resignation, BV SUYS INVEST (bestuurder)
- Director appointment, Mence BV (bestuurder)
- Permanent representative, Morgane Suys
- Power of attorney, Baker Tilly Accountants & Belastingadviseurs BV
2025
24-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
15-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
20-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
22-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 22 days late
2021
31-12
Financial
Back to profitnet €51k
Net result €51k after 3 loss-making years.
31-12
Financial
Equity above €150kEq €194k ▲32.8%
Equity rises from €146k to €194k.
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 61 days late
2020
21-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 52 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
23-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
04-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 4 days late
2016
08-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2026
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
05-08-2026
Resigned as Director
Location & real-estate footprint
Registered office, Laarne · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Dorpsstraat 299270 LaarneGround area
950 m²
Building footprint
202 m²
Volume, LiDAR
1,120 m³
Parcel 42010C0105/00Z000, Flanders · tallest building 10.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Suys
since 20042.134.898.140
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42010C0105/00Z000 | Flanders | 950 m² | 1 · 202 m² | 10.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Recognitions · licences · registrations
Food safety, FASFC
1 siteLaarne2.134.898.140
Similar companies · same sector, comparable size
PHARMACIE DE LAUZELLE
BE 0466.774.391
Ottignies-Louvain-la-Neuve · Eq €185k
PHARDUP
BE 0433.142.810
Etterbeek · Eq €185k
Pharmacie des Bastions
BE 0452.876.172
Tournai · Eq €185k
APOTEEK DE DECKER
BE 0437.713.785
Lebbeke · Eq €186k
VISA PHARMA
BE 0501.813.959
Chaudfontaine · Eq €185k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,584 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-01-2004
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:093691483